Affiliation:
1. Department of Surgery The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center Columbus Ohio USA
2. Department of Surgery Stanford University Stanford California USA
Abstract
ABSTRACTIntroductionGiven the importance of understanding COVID‐19–positive donor incidence and acceptance, we characterize chronological and geographic variations in COVID‐19 incidence relative to COVID‐19–positive donor acceptance.MethodsData on deceased donors and recipients of liver and kidney transplants were obtained from the UNOS database between 2020 and 2023. Hierarchical cluster analysis was used to assess trends in COVID‐19–positive donor incidence. Posttransplant graft and patient survival were assessed using Kaplan–Meier curves.ResultsFrom among 38 429 deceased donors, 1517 were COVID‐19 positive. Fewer kidneys (72.4% vs. 76.5%, p < 0.001) and livers (56.4% vs. 62.0%, p < 0.001) were used from COVID‐19–positive donors versus COVID‐19–negative donors. Areas characterized by steadily increased COVID‐19 donor incidence exhibit the highest transplantation acceptance rates (92.33%), followed by intermediate (84.62%) and rapidly increased (80.00%) COVID‐19 incidence areas (p = 0.016). Posttransplant graft and patient survival was comparable among recipients, irrespective of donor COVID‐19 status.ConclusionsRegions experiencing heightened rates of COVID‐19–positive donors are associated with decreased acceptance of liver and kidney transplantation. Similar graft and patient survival is noted among recipients, irrespective of donor COVID‐19 status. These findings emphasize the need for adaptive practices and unified medical consensus in navigating a dynamic pandemic.